Visual Instillation of Sphenopalatine-block Intervention for ONgoing Migraine

(VISION Trial)

SC
Overseen ByStudy Coorinator
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Association of Migraine Disorders
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this double-blinded, randomized placebo controlled clinical trial is to to see if using a numbing medicine (lidocaine) on certain areas inside the nose can help with headaches, neck pain, facial pain and pressure, and other symptoms. It also aims to understand the pathophysiology that causes these symptoms.

The main questions it aims to answer are:

1. Is applying numbing medication directly to the sphenopalatine ganglion (SPG) area, while watching through the scope to make sure it's in the right place, a workable and effective way to treat migraine headaches immediately and 24 hours?

2. Is applying numbing medication directly to the sphenopalatine ganglion (SPG) area, while watching through the scope to make sure it's in the right place, a workable and effective way to improve patient-reported outcomes?

The 2-month study requires:

* One virtual visit (on the computer)

* One visit to the office for placement of the numbing medicine under direct vision

* Daily headache diary entries that take less than two minutes to complete

Who Is on the Research Team?

JS

Jerry Schreibstein, MD

Principal Investigator

Ear, Nose, & Throat Surgeons of Western New England

Are You a Good Fit for This Trial?

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Topical lidocaine endoscopically-guided intranasal nerve blockExperimental Treatment1 Intervention
Group II: Placebo (saline) endoscopically-guided intranasal nerve blockPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Association of Migraine Disorders

Lead Sponsor